30478-91-2 Usage
General Description
6-MethylnicotinicacidN-oxide is a chemical compound that is a derivative of nicotinic acid. It is known for its use in pharmaceuticals and research as a building block for the synthesis of various drugs and compounds. 6-MethylnicotinicacidN-oxide has been found to have potential as a pharmacological agent, with research suggesting possible anti-inflammatory and neuroprotective properties. The structure of 6-MethylnicotinicacidN-oxide includes a methyl group attached to the pyridine ring, which contributes to its unique chemical properties and potential applications in drug development and medical research. Further studies on the biological activities and therapeutic potential of this compound are ongoing and may lead to its use in various medical applications in the future.
Check Digit Verification of cas no
The CAS Registry Mumber 30478-91-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 3,0,4,7 and 8 respectively; the second part has 2 digits, 9 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 30478-91:
(7*3)+(6*0)+(5*4)+(4*7)+(3*8)+(2*9)+(1*1)=112
112 % 10 = 2
So 30478-91-2 is a valid CAS Registry Number.
30478-91-2Relevant articles and documents
Structure-based design, synthesis, and biological evaluation of imidazo[1,2-b]pyridazine-based p38 MAP kinase inhibitors
Kaieda, Akira,Takahashi, Masashi,Takai, Takafumi,Goto, Masayuki,Miyazaki, Takahiro,Hori, Yuri,Unno, Satoko,Kawamoto, Tomohiro,Tanaka, Toshimasa,Itono, Sachiko,Takagi, Terufumi,Hamada, Teruki,Shirasaki, Mikio,Okada, Kengo,Snell, Gyorgy,Bragstad, Ken,Sang, Bi-Ching,Uchikawa, Osamu,Miwatashi, Seiji
, p. 647 - 660 (2018/01/03)
We identified novel potent inhibitors of p38 MAP kinase using structure-based design strategy. X-ray crystallography showed that when p38 MAP kinase is complexed with TAK-715 (1) in a co-crystal structure, Phe169 adopts two conformations, where one intera
